NH THERAGUIX SAS

Press Releases NH TherAguix SAS

Equities

ALNHT

FR0013105954

Real-time Euronext Paris Other stock markets 08:34:17 2021-10-21 pm EDT			5-day change	1st Jan Change
0.01 ^EUR	-.--%		-.--%	-.--%

2021

NH TherAguix SAS and Carbogen AMCIS AG Announce the Release of New Batch of AGuIX Drug Product for Clinical Trials

CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NH TherAguix SAS : announces the publication of promising preclinical results of AGuIX® in combination with targeted radioligand therapies (TRT)	Dec. 19	PU
NH TherAguix SAS : appoints Vincent Carrère as Chief Executive Officer	23-09-12	PU
NH TherAguix SAS : announces communications to be presented at the AAPM meeting by Harvard Medical Schools collaborators	23-07-20	PU
NH TherAguix SAS : announces the arrival of Aurélien Meyzaud as Head of Intellectual Property and Business Intelligence	23-01-13	PU
NH TherAguix SAS : announces the thesis defense of Dr. Paul Rocchi as the first NHT-funded PhD student	22-11-09	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW